This year, our team turned out on foot and on bike at races across the United States (and beyond) to support cancer survivors and raise awareness. Along the way, many shared the personal "why" that inspires them to be part of the fight against cancer.
Teams and events pictured:
Redwood City, CA at Susan G. Komen's "More than Pink" Walk
Boston, MA at LUNGevity Foundation's "Breath Deep Walk to Stop Lung Cancer"
Madison, WI and Boston, MA at Colon Cancer Coalition's "Get Your Rear in Gear"
Madison, WI at Esophageal Cancer Action Network's "Steps to Save Lives"
London, U.K. at London to Brighton Cycle Ride (Team Exact riding for Breast Cancer Now)
Related Content
Community Engagement
Exact Sciences Hosts Maydm Interns
This summer, Exact Sciences worked with Maydm, a community partner, to host four interns interested in science, technology, engineering and math (STEM) fields. ...
Community Engagement
Exact Sciences takes part in Habitat for Humanity Frame Up
Exact Sciences takes part in Habitat for Humanity Frame Up...
Community Engagement
Forward Spirit Focus: Feeding America
Exact Sciences is proud to team up with Feeding America®, the largest domestic hunger-relief organization in the United States...
Attachments
Original Link
Original Document
Permalink
Disclaimer
EXACT Sciences Corporation published this content on 03 December 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 03 December 2021 16:01:02 UTC.
Exact Sciences Corporation is a global advanced cancer diagnostics company. The Company provides a portfolio of products for earlier cancer detection and treatment guidance. Its products and services focus on screening and precision oncology tests. The Company is focusing its research and development efforts on three main areas: Colorectal Cancer Screening, MCED Test Development and MRD Test Development. The Companyâs products and services include Cologuard test, Oncotype DX Breast Recurrence Score Test, Oncotype DX Breast DCIS Score Test, Oncotype DX Colon Recurrence Score Test, and OncoExTra Test. The Companyâs flagship screening product, the Cologuard test, is a non-invasive, stool-based deoxyribonucleic acid (sDNA) screening test that utilizes a multi-target approach to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. The Oncotype DX Breast Recurrence Score test examines the activity of 21 genes in a patientâs breast tumor tissue.
EXACT SCIENCES CORPORATION 
